AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter. | TechCrunch
AI's impact in science is exemplified by DeepMind's protein structure predictions, but characterizing treatment candidates remains a significant challenge.
Breakout Ventures raises $114M fund to back AI science startups | TechCrunch
Breakout Ventures closed a $114 million Fund III to invest in AI-focused early-stage startups in scientific fields like biology and chemistry, targeting at least 20 companies with average checks of $500,000 to $5 million.
New OpenAI tool renews fears that "AI slop" will overwhelm scientific research
OpenAI's free Prism workspace streamlines LaTeX scientific writing with GPT-5.2 but risks accelerating a flood of low-quality AI-assisted papers into journals.
Mark Zuckerberg, Priscilla Chan shift philanthropy focus to how AI can accelerate science | Fortune
Chan and Zuckerberg are shifting most philanthropy to Biohub to use AI-based cell models and immune-focused research to accelerate disease detection, prevention, and treatment.
What's it like to work with an AI team of virtual scientists?
Montine constructed a team of six artificial-intelligence characters, all powered by a commercial large language model, to examine possible treatments for Alzheimer's disease.